The USA truly is a land of innovation. One adult in eight there is currently taking a GLP-1 drug such as Ozempic or Wegovy.1 Within six months, their households spend 5.3% less on groceries and 8%…
The 2026 AIPPI World Congress, held in Hamburg from 7 to 10 October, brought together IP practitioners, judges, industry representatives and academics from around the world. Its patent programme…
A compass worth havingThe 7th Civil Chamber of the Landgericht München I has done something no European court had done before. On 13 August 2026 it published guidelines, sixty-seven pages long,…
Winning the jurisdiction argument in a long-arm case is not the same as having a claim. On 2 June 2026 the UPC Court of Appeal confirmed that the Mannheim Local Division had been right to hear…
The first question before a European launch is not whether the product infringes. It is where, against whom, on what record and on what timetable that question will be tested. Market-entry opinions…
The UK Supreme Court has considered the fundamental principles of (F)RAND, this time in the context of a jurisdiction challenge in Tesla v InterDigital and Avanci. In what could prove to be a…
On March 3, 2026, the Osaka District Court dismissed a patent infringement lawsuit seeking an injunction against a generic drug, addressing an unprecedented question regarding the scope of extended…
As discussed in my previous post on this Blog, the UPC’s current approach of granting pan-UPC relief across all the Contracting Member States (CMS), based merely on a formal reliance on Article 34…
Arbitration as a Distinct Procedural ProductArbitration is more ambitious than mediation, and that ambition has a price. It promises a private, specialized, and enforceable decision rendered by…